What are the indications for mitral valve repair?

Indications for Mitral Valve Repair

Mitral valve repair is indicated for all patients with chronic severe primary mitral regurgitation (MR) who are symptomatic (NYHA class II or greater) with LVEF >30%, and for asymptomatic patients with LV dysfunction (LVEF 30-60% or LVESD ≥40 mm). 1, 2, 3

Primary (Degenerative) Mitral Regurgitation

Class I Indications (Must Repair)

Symptomatic patients:

• Chronic severe primary MR with symptoms (Stage D) and LVEF >30% 1, 3
• Severe MR defined as: ERO ≥0.40 cm², regurgitant volume ≥60 mL, regurgitant fraction ≥50%, vena contracta ≥0.7 cm 1

Asymptomatic patients with LV dysfunction:

• LVEF 30-60% and/or LVESD ≥40 mm (Stage C2) 1, 2, 3
• This threshold exists because waiting beyond these parameters leads to irreversible LV dysfunction and worse outcomes

Concomitant cardiac surgery:

• Any patient with severe primary MR undergoing CABG or other cardiac surgery 3

Class IIa Indications (Should Strongly Consider)

Asymptomatic patients with preserved LV function (LVEF >60% and LVESD <40 mm, Stage C1) when:

• Repair likelihood >95% with mortality <1% at a Heart Valve Center of Excellence 3
• OR new-onset atrial fibrillation 3
• OR pulmonary hypertension (PA systolic pressure >50 mm Hg at rest) 3

The 2017 ESC guidelines 2 support repair in asymptomatic patients when performed by experienced surgeons, emphasizing that outcomes depend heavily on surgeon experience and center volume.

Moderate primary MR:

• When undergoing cardiac surgery for other indications 3

Repair vs. Replacement Preference

Mitral valve repair is strongly preferred over replacement in all primary MR cases when feasible 1, 3:

• Posterior leaflet disease: Repair is almost always achievable and strongly recommended 3
• Anterior or bileaflet disease: Repair preferred when a successful and durable repair can be accomplished 3
• Repair provides superior survival, preserves LV function, avoids anticoagulation (with bioprosthesis) or reduces thromboembolism risk (vs. mechanical valve)

Class IIb Indications (May Consider)

• Severe symptomatic primary MR with LVEF ≤30% (Stage D) - may improve symptoms though survival benefit uncertain 3
• Rheumatic MR when durable repair is likely or anticoagulation reliability is questionable 3

Transcatheter Edge-to-Edge Repair

For primary MR:

• Severely symptomatic patients (NYHA III-IV) with prohibitive surgical risk, favorable anatomy, reasonable life expectancy, despite optimal medical therapy 3, 4
• Requires multidisciplinary team evaluation 5

Secondary (Functional) Mitral Regurgitation

The indications differ substantially because secondary MR reflects underlying LV disease rather than primary valve pathology.

Class I Indications

Concomitant CABG:

• Severe secondary MR in patients undergoing CABG with LVEF >30% 2
• This is the strongest indication for secondary MR intervention

Class IIb Indications (May Consider)

Isolated surgery for secondary MR:

• Severe secondary MR (ERO ≥0.20 cm², regurgitant volume ≥30 mL) 2
• Patients remaining symptomatic despite optimal medical therapy (including CRT if indicated) 2
• LVEF >30% 2
• Low surgical risk 2

Critical caveat: No conclusive survival benefit has been demonstrated for isolated mitral valve intervention in secondary MR 2. The 2017 ESC guidelines 2 emphasize that optimal heart failure management must be the first step, and severity should be reassessed after medical optimization.

Transcatheter edge-to-edge repair:

• Selected patients with severe secondary MR who remain severely symptomatic despite guideline-directed medical therapy (including CRT when indicated) and are at high surgical risk 6, 4
• FDA approved in 2019 for this indication 4

Key Anatomic Considerations for Repair Success

Favorable anatomy for repair includes:

• Posterior leaflet prolapse (easiest to repair) 3
• Flail width <15 mm and flail gap <10 mm 5
• Grasping zone ≥10 mm without calcification 5
• Mitral valve area ≥4.0 cm² 5

Unfavorable features suggesting replacement may be needed:

• Severe mitral annular calcification 5
• Extensive leaflet destruction
• Large interpapillary muscle distance in secondary MR 7
• Severe posterior leaflet tethering 7
• Marked LV dilatation (LVEDD >65 mm) 7

Common Pitfalls to Avoid

1. Waiting too long in asymptomatic primary MR: Once LVEF drops below 60% or LVESD exceeds 40 mm, some LV dysfunction may be irreversible 8

2. Confusing primary and secondary MR management: Secondary MR requires optimization of heart failure therapy first; isolated surgery has unclear benefit 2

3. Ignoring center experience: Repair success rates vary dramatically by surgeon and center volume 2, 9. Referral to experienced centers is essential for complex repairs

4. Missing atrial fibrillation or pulmonary hypertension: These are Class IIa indications for early repair even in asymptomatic patients with preserved LV function 3

5. Attempting repair in unfavorable anatomy: When repair is unlikely to be durable, replacement may be preferable to avoid reoperation 2